Pharmacology of ocular drugs. Oral contraceptives

G. J. Petursson, Frederick (Fritz) Fraunfelder, S. M. Meyer

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

Original languageEnglish (US)
Pages (from-to)368-371
Number of pages4
JournalOphthalmology
Volume88
Issue number4
StatePublished - 1981
Externally publishedYes

Fingerprint

Oral Contraceptives
Pharmacology
Pharmaceutical Preparations
Retinal Vessels
Color Vision
Crystalline Lens
Contact Lenses
Registries
Guidelines

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Petursson, G. J., Fraunfelder, F. F., & Meyer, S. M. (1981). Pharmacology of ocular drugs. Oral contraceptives. Ophthalmology, 88(4), 368-371.

Pharmacology of ocular drugs. Oral contraceptives. / Petursson, G. J.; Fraunfelder, Frederick (Fritz); Meyer, S. M.

In: Ophthalmology, Vol. 88, No. 4, 1981, p. 368-371.

Research output: Contribution to journalArticle

Petursson, GJ, Fraunfelder, FF & Meyer, SM 1981, 'Pharmacology of ocular drugs. Oral contraceptives', Ophthalmology, vol. 88, no. 4, pp. 368-371.
Petursson, G. J. ; Fraunfelder, Frederick (Fritz) ; Meyer, S. M. / Pharmacology of ocular drugs. Oral contraceptives. In: Ophthalmology. 1981 ; Vol. 88, No. 4. pp. 368-371.
@article{3b38f899bf95414383f49f1877e6f402,
title = "Pharmacology of ocular drugs. Oral contraceptives",
abstract = "Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.",
author = "Petursson, {G. J.} and Fraunfelder, {Frederick (Fritz)} and Meyer, {S. M.}",
year = "1981",
language = "English (US)",
volume = "88",
pages = "368--371",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Pharmacology of ocular drugs. Oral contraceptives

AU - Petursson, G. J.

AU - Fraunfelder, Frederick (Fritz)

AU - Meyer, S. M.

PY - 1981

Y1 - 1981

N2 - Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

AB - Based on literature and data in the National Registry of Drug-Induced Ocular Side Effects, the current status of oral contraceptives and adverse ocular effects is presented. The possible relationship of this group of drugs to retinal vascular disorders, color vision, macular or retinal abnormalities, neuro-ophthalmic disorders, and contact lens wear is reviewed. An overview of current guidelines for the management of patients on oral contraceptives from the ophthalmic viewpoint is presented.

UR - http://www.scopus.com/inward/record.url?scp=0019559698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019559698&partnerID=8YFLogxK

M3 - Article

C2 - 6973118

AN - SCOPUS:0019559698

VL - 88

SP - 368

EP - 371

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 4

ER -